Projects per year
Fingerprint
Dive into the research topics where Isabel Cuella Martin is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 2 Active
-
FA5 RWANDA: Make Rwandan institutes leaders in infectious diseaseprevention, diagnosis and control
Rigouts, L., Rosanas-Urgell, A., Kattenberg, E., de Jong, B., Cuella Martin, I., Mitchell, E., Theunissen, C., Polman, K., Trevisan, C., Ravinetto, R., Roosen, T., Rosanas-Urgell, A. & de Jong, B.
Directorate-General for Development Cooperation and Humanitarian Aid
1/01/22 → 31/12/26
Project: Development project
-
Curbing rifampicin-resistant tuberculosis in Rwanda and beyond
Cuella Martin, I., de Jong, B. & Rigouts, L.
30/06/21 → …
Project: PhD-project
Research output
- 4 A1: Web of Science-article
-
Direct thin-layer agar for bedaquiline-susceptibility testing of Mycobacterium tuberculosis at BSL2 level yields high accuracy in 15 days from sputum processing
Cuella-Martin, I., Runyambo, D., De Bock, S., Diels, M., Niyompano, H., Hakizayezu, F., Keysers, J., De Rijk, WB., Habimana, YM., Gahamanyi, N., Ardizzoni, E., Muvunyi, CM., de Jong, BC., Ngabonziza, JCS. & Rigouts, L., 2025, In: Journal of Clinical Microbiology. 63, 4, 11 p.Research output: Contribution to journal › A1: Web of Science-article › peer-review
Open Access -
Paucibacillary Tuberculosis drives the low positive predictive value of Xpert MTB/RIF Ultra for Rifampicin resistance detection in low-prevalence settings
Cuella-Martin, I., Hakizayezu, F., Ahmed, A., Runyambo, D., Niyompano, H., Keysers, J., De Rijk, WB., Mulders, W., Mitchell, EMH., Decroo, T., Habimana, YM., Migambi, P., Muvunyi, CM., de Jong, BC., Rigouts, L. & Ngabonziza, JCS., 2025, (E-pub ahead of print) In: Clinical Infectious Diseases. 7 p.Research output: Contribution to journal › A1: Web of Science-article › peer-review
Open Access -
Safety of high-dose amikacin in the first week of all-oral rifampicin-resistant tuberculosis treatment for the prevention of acquired resistance (STAKE): protocol for a single-arm clinical trial
Snobre, J., Gasana, J., Ngabonziza, JCS., Cuella-Martin, I., Rigouts, L., Jacobs, BK., de Viron, E., Herssens, N., Ntihumby, JB., Klibazayre, A., Ndayishimiye, C., Van Deun, A., Affolabi, D., Merle, CS., Muvunyi, C., Sturkenboom, MGG., Migambi, P., de Jong, BC., Mucyo, Y. & Decroo, T., 2024, In: BMJ Open. 14, 7, 9 p., e078379.Research output: Contribution to journal › A1: Web of Science-article › peer-review
Open Access -
Rifampicin resistance conferring mutations among Mycobacterium tuberculosis strains in Rwanda
Cuella-Martin, I., Semuto Ngabonziza, J. C., Torrea, G., Meehan, C. J., Mulders, W., Ushizimpumu, B., Weerdt, L. D., Keysers, J., De Rijk, W. B., Decroo, T., De Jong, B. C. & Rigouts, L., 2023, In: International Journal of Mycobacteriology. 12, 3, p. 274-281 8 p.Research output: Contribution to journal › A1: Web of Science-article › peer-review
Open AccessFile182 Downloads (Pure)